The new capability supports tables, figures, and diagrams with spatial metadata, making documents searchable and actionable in AI workflows.
Novartis has reached an agreement to buy Regulus Therapeutics and its experimental therapy for autosomal dominant polycystic kidney disease (ADPKD) for $800 million upfront in a deal that could have a ...